Survey of Neutrophil to Lymphocyte Ratio as Prognostic Factor in Colorectal Cancer

被引:0
|
作者
Farshchian, Negin [1 ,2 ]
Soleimani, Maral [2 ]
Heydarheydari, Sahel [3 ]
Farshchian, Nazanin [2 ,4 ]
机构
[1] Kermanshah Univ Med Sci, Fac Med, Dept Radiat Oncol, Kermanshah, Iran
[2] Imam Reza Hosp, Clin Res Dev Ctr, Kermanshah, Iran
[3] Kermanshah Univ Med Sci, Fac Med, Dept Med Phys, Kermanshah, Iran
[4] Kermanshah Univ Med Sci, Fac Med, Dept Radiol, Kermanshah, Iran
关键词
Colorectal cancer (CRC); Neutrophil-lymphocyte ratio (NLR); Prognostic Factor; PREOPERATIVE NEUTROPHIL; TO-LYMPHOCYTE; RESECTION; OUTCOMES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Neutrophil-lymphocyte ratio (NLR) is derived from the neutrophil and lymphocyte count obtained from routine complete blood count with the differential test (CBC/diff). The aim of the present study is to determine the relationship between NLR with prognostic factors in colorectal cancer. Material and Methods: A total of 70 patients with colorectal cancer were studied according to the research objectives. Independent T-test and Mann-Whitney U Mann-Whitney test were used to compare the NLR with qualitative variables such as pathology type. Pearson or Spearman correlation coefficient was used for correlating the quantitative variables. The significance level was considered as P<0.05. Results: Most of the enrolled patients were in the age group of 60-69 years (31.5%). The mean and standard deviation of NLR was 2.1 +/- 0.1. Only 4.3% of the subjects had NLR greater than 5. The association between NLR with N-stage (P=0.005) and inflammatory factor (CRP) was statistically significant (P = 0.016). The correlation between NLR and these variables showed that Grade (P=0.091), PNI (P=0.093), LDH (P=0.20), diabetes (P=0.264), M-stage (P=0.282), ESR (P=0.386), LVSI (P=0.473), T-stage (P=0.527), CEA (P=0.582), and BMI (P=0.681) with NLR was not meaningful. Conclusion: NLR can be associated with prognosis and risk of disease progression, especially in lymph nodes. Since NLR does not require additional testing and request and is quite easy and cost-effective, it is recommended considering this ratio during the initial assessment and the classification of the risk and stage of the disease.
引用
收藏
页码:319 / 323
页数:5
相关论文
共 50 条
  • [21] Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage Ⅲ and Ⅳ colorectal cancer
    Jae Hyun Kim
    Jun Yeop Lee
    Hae Koo Kim
    Jin Wook Lee
    Sung Gyu Jung
    Kyoungwon Jung
    Sung Eun Kim
    Won Moon
    Moo In Park
    Seun Ja Park
    World Journal of Gastroenterology, 2017, (03) : 505 - 515
  • [22] Prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with colorectal cancer.
    Kim, Jae Hyun
    Park, Seun Ja
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [23] Neutrophil lymphocyte ratio and Platelet lymphocyte ratio as a prognostic factor in brain metastases
    Niiya, A.
    Murakami, K.
    Kobayashi, R.
    Toyofuku, K.
    Nishimura, E.
    Kato, M.
    Ozawa, Y.
    Shinjo, H.
    Miyaura, K.
    Morota, M.
    Serizawa, T.
    Ito, Y.
    Imai, A.
    Kagami, Y.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S384 - S385
  • [24] Pre-operative neutrophil lymphocyte ratio greater than 5 is a prognostic factor for recurrent colorectal cancer
    Mallappa, S.
    Sinha, A.
    Gupta, S.
    Chadwick, S. J. D.
    BRITISH JOURNAL OF SURGERY, 2011, 98 : 15 - 16
  • [25] Prognostic biomarkers in metastatic colorectal cancer: delta prognostic nutritional index, delta neutrophil to lymphocyte ratio, and delta platelet to lymphocyte ratio
    Kocak, Mehmet Zahid
    Coban, Seda
    Araz, Murat
    Eryilmaz, Melek Karakurt
    Artac, Mehmet
    SUPPORTIVE CARE IN CANCER, 2023, 31 (06)
  • [26] Prognostic biomarkers in metastatic colorectal cancer: delta prognostic nutritional index, delta neutrophil to lymphocyte ratio, and delta platelet to lymphocyte ratio
    Mehmet Zahid Kocak
    Seda Coban
    Murat Araz
    Melek Karakurt Eryilmaz
    Mehmet Artac
    Supportive Care in Cancer, 2023, 31
  • [27] Neutrophil–lymphocyte ratio as a prognostic factor in laryngeal carcinoma
    Yılmaz B.
    Şengül E.
    Gül A.
    Alabalık U.
    Özkurt F.E.
    Akdağ M.
    Topçu İ.
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2018, 70 (2) : 175 - 179
  • [28] Neutrophil/lymphocyte ratio (NLR) as a prognostic factor in biliary tract cancer (BTC)
    McNamara, Mairead Geraldine
    Templeton, Arnoud J.
    Maganti, Manjula
    Walter, Thomas
    Horgan, Anne M.
    McKeever, Elizabeth
    Min, Trisha
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [29] Neutrophil-lymphocyte ratio as a predictive factor for tumor staging in colorectal cancer
    Ozgehan, Gulay
    Kahramanca, Sahin
    Kaya, Ismail Oskay
    Bilgen, Koksal
    Bostanci, Hasan
    Guzel, Hakan
    Kucukpinar, Tevfik
    Kargici, Hulagu
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2014, 44 (03) : 365 - 368
  • [30] Neutrophil-to-lymphocyte ratio as a prognostic factor in upper tract urothelial cancer
    Mirza, Moben
    BJU INTERNATIONAL, 2014, 114 (03) : 316 - 317